Evidence of underdiagnosis of myasthenia gravis in older people.
about
The emerging diversity of neuromuscular junction disordersFactors predicting the outcomes of elderly hospitalized myasthenia gravis patients: a national database study.A systematic review of population based epidemiological studies in Myasthenia Gravis.The Concomitant Association of Thyroid Disorders and Myasthenia GravisNationwide population-based epidemiological study of myasthenia gravis in taiwanRepeated acetylcholine receptor antibody-concentrations and association to clinical myasthenia gravis development.Current and emerging therapies for the treatment of myasthenia gravis.Update on myasthenia gravis.John Newsom-Davis: clinician-scientist and so much more.Treatment of Myasthenia Gravis in Patients with Elderly Onset at Advanced AgeDysphonia as first symptom of late-onset myasthenia gravis.Lambert-Eaton myasthenic syndrome in a patient with small-cell lung cancer: A case reportCauses of death among patients with myasthenia gravis in Norway between 1951 and 2001.Clinical and serological study of myasthenia gravis in HuBei Province, China.Myasthenia gravis: a long term follow-up study of Swedish patients with specific reference to thymic histology.Unusual case of recurrent falls: myasthenia gravis in an elderly patientImmunology of disorders of neuromuscular transmission.The Epidemiology of Myasthenia Gravis in Korea.Autoimmune channelopathies.Myasthenia gravis: a clinical-immunological update.Incidence and Prevalence of Myasthenia Gravis in Korea: A Population-Based Study Using the National Health Insurance Claims Database.Autoantibodies in neuromuscular transmission disorders.Diagnostic use of autoantibodies in myasthenia gravis.Clinical aspects of myasthenia explained.Autoantibodies in neuromuscular autoimmune disorders.Myasthenia gravis in Ceará, Brazil: clinical and epidemiological aspects.Treatment of myasthenia gravis: focus on pyridostigmine.Anesthesia and myasthenia gravis.Thymus, thymoma and myasthenia gravis.Late-onset myasthenia gravis: a review when incidence in older adults keeps increasing.Treatment of Myasthenia Gravis in the Aged.Frequencies of neuronal autoantibodies in healthy controls: Estimation of disease specificity.Myasthenia gravis: recent advances in immunopathology and therapy.Clinical Evaluation of Blepharoptosis: Distinguishing Age-Related Ptosis from Masquerade Conditions.Statin-associated weakness in myasthenia gravis: a case report.Epidemiology of myasthenia gravis in Northern Portugal: Frequency estimates and clinical epidemiological distribution of cases.Case report: A young man with progressive weakness, double vision and breathlessness.The clinical spectrum of Caspr2 antibody-associated disease.Myasthenia gravis requiring pyridostigmine treatment in a national population cohort.Late-onset myasthenia not on the increase: a nationwide register study in Denmark, 1996-2009.
P2860
Q24595915-7FF40FEE-CC53-4F78-A7A6-AE760E41686EQ33601700-45DEF68F-9278-4708-ABCC-448A2A10EFE3Q33611231-CE15F641-8CD0-419E-A25C-C31B829D79C4Q33726103-4D8DE0B0-0213-4000-8E60-442675FBDA0BQ34057165-1306B9B5-69E5-4F55-B1E7-2A797C4F06CCQ34612356-F8B35DDE-2EE2-424F-8B36-08F534825193Q34879129-0DF539FD-5C62-4CC5-8A68-C83C24FB630AQ35520740-8E987913-1C53-4829-968E-A8C59E51C032Q35606729-5BA3E87F-92D6-437C-B2CE-0F83E9826FAEQ35886852-DB5340B4-AEF4-4640-9CA2-60D606313CF8Q35901349-A26E5A70-F4D9-4592-B00F-71C8204C527EQ35943155-A9240EBB-E861-4D4B-B979-06879589522FQ36142463-9A898A2C-B080-4BC7-A22C-37654CA0D3FAQ36143252-C1DEAD9C-A459-4B58-9094-77AF6D309CFDQ36226648-F03A7621-87EA-4B28-A26A-9512E95AA992Q36398761-F74838DC-EB68-4707-8BCB-87DBD78005E3Q36459475-5FEFEEBE-888C-4A2C-8B72-3A3EC9AAE160Q36541587-50E8B15E-9EBF-4DAD-9ECE-2E869CA8AC82Q36577209-64E4EFE5-1B1D-4DD4-BC97-CAA2DE0E4FE9Q36783864-4365E922-49E0-4AE0-A01A-F64C14B3AA8CQ37124330-C92649F3-8B8F-43D5-9D3A-4A60E6EDB8F9Q37409082-D5056623-32FA-4AEF-9196-986DA8A473FBQ37727987-751D699F-B814-434A-8922-AF2903C7F891Q37727997-65A13052-3AC4-4AD9-A256-5066C463FB76Q37754738-2731164D-5EF6-49AD-81DA-8F032371EAFFQ37829650-8F16D47F-012E-4F3B-B5EA-A2499B4CF9C1Q37911501-896666D7-0B9A-42E6-B20E-540BD04F347EQ37957167-A3B0AE69-4B92-4697-A8CF-F6F0BFE71052Q38040680-7CF53B75-0CA5-4BAB-A708-0ACCD885CE8CQ38124827-5C3DF8B2-BCA8-4C83-9161-BF2BE142366DQ38585652-7205F645-991D-4C47-AEC1-CD5EF6F4AE64Q38648896-16631137-C03A-41B7-9612-97198B18F0C6Q38969032-6CEEF6B5-F9B1-44EB-8A82-E1C45F472CEAQ39158982-C794E002-D81C-4945-BB4D-11661E354A10Q39490425-B12E6E29-FC39-4E8E-849A-3E0880B844CFQ40017924-91FCC1A7-F2EA-42EA-B511-E1431D5ECC16Q41596631-9627917D-FCC7-48EC-85D5-6EB4C72432D8Q42385999-2ED1FE41-280A-4832-BF54-F7D7FCFBE4B3Q43057271-A6590E2C-38F3-4B8F-9980-DEE051DEC769Q43910058-E0271F6D-5514-4810-9019-CABE292FC79F
P2860
Evidence of underdiagnosis of myasthenia gravis in older people.
description
2003 nî lūn-bûn
@nan
2003 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Evidence of underdiagnosis of myasthenia gravis in older people.
@ast
Evidence of underdiagnosis of myasthenia gravis in older people.
@en
type
label
Evidence of underdiagnosis of myasthenia gravis in older people.
@ast
Evidence of underdiagnosis of myasthenia gravis in older people.
@en
prefLabel
Evidence of underdiagnosis of myasthenia gravis in older people.
@ast
Evidence of underdiagnosis of myasthenia gravis in older people.
@en
P2093
P2860
P356
P1476
Evidence of underdiagnosis of myasthenia gravis in older people.
@en
P2093
J Grimley Evans
P M Rothwell
UK Myasthenia Gravis Survey
P2860
P304
P356
10.1136/JNNP.74.8.1105
P407
P577
2003-08-01T00:00:00Z